As Of	Filer	Filing¹	For·On·As	Docs:Size	Issuer		Filing Agent

 3/29/24  Adorbs Inc.                       NT 10-K    12/31/23    1:22K                                    Empire Filings/FA        
11/20/23  Adorbs Inc.                       10-Q        9/30/23   41:2.4M                                   Empire Filings/FA        
11/13/23  Adorbs Inc.                       NT 10-Q     9/30/23    1:24K                                    Empire Filings/FA        
10/27/23  Soul Biotechnology Corp.          8-K:5,9    10/24/23   11:2.1M                                   Empire Filings/FA        
 10/4/23  Soul Biotechnology Corp.          DEF 14C     10/4/23    1:243K                                   Empire Filings/FA        
 9/27/23  Soul Biotechnology Corp.          10-Q        6/30/23   41:2.4M                                   Empire Filings/FA        
 9/15/23  Soul Biotechnology Corp.          PRE 14C     9/15/23    1:244K                                   Empire Filings/FA        
 8/14/23  Soul Biotechnology Corp.          NT 10-Q     6/30/23    1:18K                                    Empire Filings/FA        
 8/14/23‡ Soul Biotechnology Corp.          RW          8/11/23    1:10K                                    Empire Filings/FA        
  8/7/23  Soul Biotechnology Corp.          S-1                   41:5.4M                                   Empire Filings/FA        
 5/15/23  Soul Biotechnology Corp.          10-Q        3/31/23   38:2.2M                                   Empire Filings/FA        
 3/13/23  Soul Biotechnology Corp.          8-K:5,9     3/13/23   11:211K                                   Empire Filings/FA        
 3/13/23  Soul Biotechnology Corp.          10-K       12/31/22   40:2.3M                                   Empire Filings/FA        
10/21/22  Soul Biotechnology Corp.          10-Q        9/30/22   38:2.4M                                   Empire Filings/FA        
  8/1/22  Soul Biotechnology Corp.          10-Q        6/30/22   38:2.1M                                   Empire Filings/FA        
 5/10/22  Soul Biotechnology Corp.          10-Q        3/31/22   38:1.8M                                   Empire Filings/FA        
  5/5/22  Soul Biotechnology Corp.          8-K:4,9     4/26/22   11:245K                                   Empire Filings/FA        
  4/8/22  Soul Biotechnology Corp.          DEF 14C      4/8/22    1:704K                                   Empire Filings/FA        
 3/30/22‡ Soul Biotechnology Corp.          PRE 14C     3/29/22    1:702K                                   Empire Filings/FA        
 2/10/22  Soul Biotechnology Corp.          8-K:1,2,3,5 2/10/22   14:1.2M                                   Empire Filings/FA        

____________
‡	A non-Insider-Ownership Filing that was accepted after the SEC “closed” at 5:30:00pm ET.  The legal “Filed As Of” date may be the next, or another, day.
¹	Filing/Form Types:
	8-K	Current Report — Form 8-K { Item 1: Business & Operations;  2: Financial Info;  3: Securities & Trading;  4: Accountants & Accounting;  5: Governance & Management;  6: Asset-Backed Securities;  7: Disclosures;  8: Events;  9: Financials }.
	10-K	Annual Report — Form 10-K.
	10-Q	Quarterly Report — Form 10-Q.
	DEF 14C	Definitive Proxy Info Statement — Schedule 14C.
	NT 10-K	Notice of a Late Filing of a Form 10-K Annual Report — Form 12b-25.
	NT 10-Q	Notice of a Late Filing of a Form 10-Q Quarterly Report — Form 12b-25.
	PRE 14C	Preliminary Proxy Info Statement — Schedule 14C.
	RW	Registration Withdrawal Request.
	S-1	Registration Statement (General Form) — Form S-1.